The importance of CCR5 becomes apparent when considering a CCR5 antagonist initiated days before the clinical arthritis manifestation was able to attenuate leukocyte migration to joints thereby reducing disease severity (160). The gene discussed is CCR5; the disease is arthritic joint disease.